By vgreene, 7 April, 2020 An Open Label Phase 1 Trial of Losartan for Worsening Respiratory Illness in COVID-19, NCT04335123
By vgreene, 7 April, 2020 Phase 2 Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection, NCT04335552
By vgreene, 7 April, 2020 Hydroxychloroquine vs Azithromycin for Outpatients in Utah With COVID-19 (HyAzOUT): A Prospective Pragmatic Trial, NCT04334382
By vgreene, 7 April, 2020 Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine Trial (HERO-HCQ Trial), NCT04334148
By vgreene, 7 April, 2020 Phase 2 Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection, NCT04335552
By vgreene, 7 April, 2020 An Open Label Phase II Pilot Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection, NCT04335084
By vgreene, 7 April, 2020 Hydroxychloroquine vs Azithromycin for Outpatients in Utah With COVID-19 (HyAzOUT): A Prospective Pragmatic Trial, NCT04334382
By vgreene, 7 April, 2020 Pre-exposure Prophylaxis for SARS-Coronavirus-2: A Pragmatic Randomized Clinical Trial, NCT04328467
By vgreene, 7 April, 2020 A Phase 1b, Randomized, Double-blinded, Placebo-controlled Study of Hydroxychloroquine in Outpatient Adults With COVID-19, NCT04333654